Histone H2A.Z Activators
Histone H2A.Z activators are a group of chemicals that can influence the incorporation and function of the histone variant H2A.Z within chromatin. These activators primarily operate through epigenetic mechanisms, modulating histone modifications and chromatin structure, ultimately impacting gene expression and cellular processes. HDAC inhibitors lead to hyperacetylation of histones, creating a more open chromatin conformation that can favor the incorporation of H2A.Z. This acetylation-induced chromatin relaxation allows H2A.Z to be deposited into nucleosomes, affecting gene expression. Additionally, activators which exhibit HDAC inhibitory properties similar to valproic acid, can indirectly influence H2A.Z by impacting histone acetylation and chromatin structure. Activators of this class modulate histone acetylation, potentially affecting H2A.Z incorporation. Furthermore, activators can increase histone acetylation levels, potentially promoting H2A.Z deposition onto chromatin.
Another category of H2A.Z activators includes DNA methyltransferase inhibitors. These activators can induce changes in DNA methylation patterns, which may indirectly affect H2A.Z occupancy. Alterations in DNA methylation can impact the binding of chromatin remodeling complexes to H2A.Z, influencing its role in transcriptional regulation. Additionally, activators can modulate chromatin accessibility, indirectly affecting H2A.Z incorporation. They can disrupt the binding of BET proteins to acetylated histones, leading to changes in chromatin structure and potentially impacting the dynamics of H2A.Z-containing nucleosomes. Lastly, activators can influence gene expression by modulating histone modifications, indirectly impacting H2A.Z activity. These histone H2A.Z activators operate through various epigenetic mechanisms, ultimately affecting chromatin structure and gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor that induces histone hyperacetylation, leading to an open chromatin structure, potentially favoring H2A.Z deposition. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate inhibits HDACs, promoting histone acetylation and chromatin relaxation, which can indirectly impact H2A.Z incorporation. | ||||||
Trichloroethylene | 79-01-6 | sc-251310 sc-251310A | 500 ml 1 L | $66.00 $110.00 | ||
Trichloroethylene is associated with HDAC inhibition, potentially influencing histone acetylation levels and chromatin structure, which can indirectly impact H2A.Z activity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, an HDAC inhibitor, increases histone acetylation levels, potentially favoring the deposition of H2A.Z into nucleosomes. | ||||||
Allyl disulfide | 2179-57-9 | sc-252359 | 25 g | $80.00 | ||
Allyl disulfide found in garlic, has HDAC inhibitory activity that can lead to histone hyperacetylation, potentially affecting H2A.Z incorporation. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
Sodium phenylbutyrate is an HDAC inhibitor that increases histone acetylation levels, potentially promoting H2A.Z deposition onto chromatin. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine is a DNA methyltransferase inhibitor that induces changes in DNA methylation patterns, indirectly affecting H2A.Z occupancy. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108, similar to Decitabine, is a DNA methyltransferase inhibitor that can influence DNA methylation patterns, potentially impacting H2A.Z activity. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET inhibitor, modulates chromatin accessibility by disrupting BET protein binding to acetylated histones, indirectly affecting H2A.Z dynamics. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol modulates gene expression by influencing histone modifications, indirectly impacting H2A.Z activity through epigenetic mechanisms. | ||||||